Physician profile
Eugene E Isaac
NPI 1265755425
$3,945.10
in general payments reported to CMS, 2019-2025
22 companies · $497 in 2025
The $497 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $290 · 2022: $1,846 · 2023: $693 · 2024: $620 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,296.09 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Cardiohelp |
| Angiodynamics, INC. | $1,200.00 | 2022 | |
| Abiomed | $220.10 | 2023-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $174.51 | 2022-2025 | Lifevest |
| Davol INC. | $140.60 | 2022-2024 | Progel Applicator Spray Tips |
| Supreme Orthopedic Systems, LLC | $128.57 | 2025 | |
| Medtronic, INC. | $117.11 | 2022 | |
| Haemonetics Corporation | $96.44 | 2022 | |
| Ethicon US, LLC | $90.15 | 2023-2024 | Prolene, Evarrest, Stratafix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.65 | 2024 | Jardiance |
| Edwards Lifesciences Corporation | $65.03 | 2022-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Stryker Corporation | $53.00 | 2024 | |
| Abbott Laboratories | $45.54 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Intuitive Surgical, INC. | $41.66 | 2021 | |
| Baxter Healthcare | $35.22 | 2024 | Coseal |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hemosonics LLC | $29.17 | 2022 | |
| Kci USA, INC. | $27.30 | 2022 | |
| Merck Sharp & Dohme LLC | $25.10 | 2024 | Keytruda |
| Boston Scientific Corporation | $24.20 | 2023 | Ekosonic |
| Atricure, INC. | $22.97 | 2024 | |
| Amarin Pharma, INC. | $20.13 | 2022 | |
| Sanara Medtech INC. | $15.56 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Isaac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.